We’re committed to being a stable funder and champion of promising biomedical research. We invite applications for our Innovator Awards from Aug 1-Sept 30. Grants will support individual and collaborative research that advances the understanding of #IBD. krfoundation.org/news/health/ib…

🔵 Interested in Global IBD and future scenarios? Very happy to see our review published in UEGJ with IBD Master and good friend Seb 👍

We’re excited to share that Propel a Cure & IBD Connect are officially organizational partners! By uniting our efforts, we’re strengthening both sides of the fight against #IBD by providing critical support for families today & fueling groundbreaking research for tomorrow. Our

Over 90% of adults carry Epstein-Barr Virus (#EBV), often without symptoms. But in a subset of genetically susceptible people, EBV may play a role in triggering Crohn’s disease—just like it’s been linked to other autoimmune conditions like multiple sclerosis and lupus.

📣 Paid research study opportunity for Crohn’s disease, Ulcerative colitis, and Micriscopic colitis patients: Propel a Cure partners with Rare Patient Voice to connect #IBD patients & caregivers with research opportunities that align with their condition or that of a loved one. By

Ecco consensus guideline on diet in #IBD is out now! huge work by Emma Halmos Richard Hansen and so many others..glad to be a small cog in this mammoth effort. academic.oup.com/ecco-jcc/advan…

🧬 What can early life tell us about #IBD? Dr. Joana Torres is investigating how early life factors & at-risk populations may hold the key to predicting who develops IBD & how the disease unfolds. Her research focuses on identifying early signals of IBD in newly diagnosed

New research highlights a copper-triggered form of cell death—cuproptosis—as a promising treatment for #IBD. Copper can both fuel and fight disease, and targeting this process could open new therapeutic pathways. news-medical.net/news/20250718/…

“What can we learn from #IBD before diagnosis?” In our interview, Dr. Joana Torres shares how studying the preclinical stage helps uncover how IBD begins—mapping immune changes and pinpointing inflammatory pathways driving disease. Full video: propelacure.org/videos

A recent review in nature suggests treatments like steroids and antifibrotics may help by shifting macrophages away from inflammatory and fibrotic states. Targeting macrophage plasticity could open new doors in autoimmune disease—including #IBD. nature.com/articles/s4158…

IBD drugs like steroids, biologics, & small molecules can alter the gut microbiome—and the microbiome can affect how those drugs work. A new review highlights this two-way interaction & its role in treatment response & the potential for more personalized care. Read here:

The FDA approval of vagus nerve stimulation for RA patients gives hope to others with immune-mediated diseases, including #IBD. #crohns #crohnsdisease

Malnutrition affects up to 85% of people with #IBD — and it’s more than just not eating enough. In Crohn’s disease and Ulcerative Colitis, factors like reduced intake, malabsorption, blood and protein loss, and bacterial overgrowth all contribute. Malnutrition and muscle loss

Big news! Our CEO, Angela Clark, was recently featured on the IBD Connect blog. In the interview, Angela shares her personal journey with Crohn’s and how it led her to lead Propel a Cure—a volunteer-run nonprofit focused on bold, early-stage research to uncover the root causes

The PIANO (Pregnancy Inflammatory bowel disease And Neonatal Outcomes) Consensus Group has developed the first Global Consensus on management of pregnancy for patients with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis. The group is led

Your experience can help shape the future of #IBD research! We’ve partnered with Rare Patient Voice to connect patients and caregivers with paid research opportunities—advancing studies on both rare and common chronic conditions, while also supporting Propel a Cure’s mission to

Thank you for such a thoughtful discussion, Amber! Watch the full video episode here: youtube.com/watch?v=MpkdPw…

Science doesn’t need to go according to plan; it just needs to lead to a discovery. If doesn’t have to be done alone or together with a buddy; there just needs to be a discovery. It doesn’t need to happen fast or slow; just as long as there’s a discovery, then everybody is happy.

"This study is the first comprehensive high-resolution analysis of the exact antigenic nature of systemic antibody responses during the transition from prediagnostic to established #IBD."